Thinking Small U.S. patent officials and other regulators must get up to speed on the intricacies of tiny particles to avoid hindering the growth of nanotechnology.
March 24, 2008 - LORI ANDREWS AND JULIE BURGER - Law - Patents
Untethering Innovation One year before a new president takes office, Congress lies low, but bills on patents, biologics, genetics, and a host of other issues could still affect R&D.
February 11, 2008 - BRADFORD PLUMER - Law - Legislation
November 01, 2007 - MARY LISBETH D'AMICO - Law - Patents
A Booby Prize Scrapping the patent system for drugs for a reward model is a bad idea
October 23, 2007 - PETER J. PITTS - Law - Patents
A Thorn in Pharma's Side Patent watchdog Dan Ravicher touts the need for patent reform after getting the U.S. government to review Gilead's patents for its leading HIV drug.
July 18, 2007 - DANIEL S. LEVINE - Law - Patents
Key Patent Ruling No Biotech Killer U.S. Supreme Court refines what "obvious" means for patents, but doesn't scrap protection for innovators.
May 16, 2007 - COURTENAY C. BRINCKERHOFF - Law - Patents
